- Home
- YMAB vs IMXI Comparison
YMAB vs IMXI Comparison
Compare YMAB & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- IMXI
- Stock Information
- Founded
- YMAB 2015
- IMXI N/A
- Country
- YMAB United States
- IMXI United States
- Employees
- YMAB N/A
- IMXI N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- IMXI Retail: Computer Software & Peripheral Equipment
- Sector
- YMAB Health Care
- IMXI Technology
- Exchange
- YMAB Nasdaq
- IMXI Nasdaq
- Market Cap
- YMAB 631.1M
- IMXI 597.4M
- IPO Year
- YMAB 2018
- IMXI N/A
- Fundamental
- Price
- YMAB $11.14
- IMXI $20.87
- Analyst Decision
- YMAB Strong Buy
- IMXI Buy
- Analyst Count
- YMAB 8
- IMXI 6
- Target Price
- YMAB $21.38
- IMXI $27.50
- AVG Volume (30 Days)
- YMAB 268.9K
- IMXI 354.8K
- Earning Date
- YMAB 11-08-2024
- IMXI 11-08-2024
- Dividend Yield
- YMAB N/A
- IMXI N/A
- EPS Growth
- YMAB N/A
- IMXI 21.49
- EPS
- YMAB N/A
- IMXI 1.80
- Revenue
- YMAB $84,553,000.00
- IMXI $665,673,000.00
- Revenue This Year
- YMAB $10.24
- IMXI $3.27
- Revenue Next Year
- YMAB $20.21
- IMXI $5.53
- P/E Ratio
- YMAB N/A
- IMXI $11.62
- Revenue Growth
- YMAB N/A
- IMXI 3.79
- 52 Week Low
- YMAB $5.17
- IMXI $16.17
- 52 Week High
- YMAB $20.90
- IMXI $23.28
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- IMXI 69.05
- Support Level
- YMAB $12.47
- IMXI $17.38
- Resistance Level
- YMAB $15.69
- IMXI $22.37
- Average True Range (ATR)
- YMAB 0.97
- IMXI 0.63
- MACD
- YMAB -0.46
- IMXI 0.36
- Stochastic Oscillator
- YMAB 9.88
- IMXI 69.94
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.